miR-21,Sprouty1功能轴调控绝经后骨质疏松患者骨髓间充质干细胞的成骨能力.doc

miR-21,Sprouty1功能轴调控绝经后骨质疏松患者骨髓间充质干细胞的成骨能力.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
miR-21,Sprouty1功能轴调控绝经后骨质疏松患者骨髓间充质干细胞的成骨能力

miR-21/Sprouty1功能轴调控绝经后骨质疏松患者 骨髓间充质干细胞的成骨能力 杨 楠1,周 威1,王 光2,丁 寅3,金 岩4(1解放军第309医院口腔科,北京市 100091;2解放军91551部队门诊部,江西省九江市 332005;解放军第四军医大学口腔医院,3正畸科,4组织工程中心,陕西省西安市 710032) 引用本文:杨楠,周威,王光,丁寅,金岩. miR-21/Sprouty1功能轴调控绝经后骨质疏松患者骨髓间充质干细胞的成骨能力[J].中国组织工程研究,2017,21():3287-3292. DOI:10.3969/j.issn.2095-4344.2017.21.002 ORCID: 0000-0003-0605-2250(杨楠) 文章快速阅读: 文题释义: miRNA:是一类具有18-25个核苷酸的非编码RNA,它通过与靶基因3’UTR区非完全配对来抑制靶基因的翻译和稳定,参与多种生物功能。 Runx2和Osterix与骨髓间充质干细胞的成骨分化miR-21/Sprouty1 function axis regulates the osteogenic differentiation of bone marrow mesenchymal stem cells after postmenopausal osteoporosis Yang Nan1, Zhou Wei1, Wang Guang2, Ding Yin3, Jin Yan4 (1Department of Stomatology, the 309th Hospital of PLA, Beijing 100091, China; 2Outpatient Department of Troop 91551, Jiujiang 332005, Jiangxi Province, China; 3Department of Orthodontics, Stomatology Hospital of Fourth Military Medical University of PLA, Xi’an 710032, Shaanxi Province, China; 4Center of Tissue Engineering, Fourth Military Medical University of PLA, Xi’an 710032, Shaanxi Province, China) Abstract BACKGROUND: Osteogenic differentiation is a complex process involving transcriptional and post-transcriptional regulation by multiple signaling pathways, and the specific mechanisms remain unclear. It is of great significance to study the role of critical miRNAs in the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) in the treatment of osteoporosis and bone defects. OBJECTIVE: To explore the regulatory ability of miR-21/Sprouty1 function axis in the osteogenic differentiation of BMSCs in patients with postmenopausal osteoporosis. METHODS: BMSCs were isolated from healthy people (H-hBMSCs) and patients with postmenopausal osteoporosis (PMOP-hBMSCs), and their osteogenic ability was compared. Expression of miR-21 and Spry1 at gene and protein levels was detected by real-time RT-PCR and western blot assay, respectively. miR-21 expression was upregulated via transfection in PMOP-hBMSCs,

文档评论(0)

almm118 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档